PITTSBURGH Feb. 6 2012 PRNewswire &160;Mylan Inc. Nasdaq MYL today announced that it has successfully completed the acquisition of two dermatological products from Valeant Pharmaceuticals. Mylan has acquired the abbreviated new drug application ANDA...
↧